Skip to main content
NUWE
NASDAQ Industrial Applications And Services

Nuwellis Reports Q2 Loss, Raises $6.7M Post-Quarter, Names New CEO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.3
Mkt Cap
$4.128M
52W Low
$1.25
52W High
$235.2
52W Position info
4.0% above low
Off High info
99% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

NUWE is trading near its 52-week low of $1.25 (4.0% above the low) on light trading volume (0.2× avg).

Summary

Nuwellis reported a Q2 net loss of $4.8 million and disclosed $6.7 million in post-quarter financing, while naming Mike McCormick as its new CEO. The company continues to face going concern and Nasdaq listing risks.


Key Events · Earnings and Guidance · NUWE

  • Q2 Net Loss of $4.8M

    Nuwellis reported a net loss of $4.8 million for Q2 2026, compared to $12.6 million in Q2 2025. Revenue grew 14.1% to $1.97 million, but operating expenses rose 20.8% to $4.67 million.

  • Post-Quarter Financing of $6.7M

    On July 31, 2026, Nuwellis closed a registered direct offering of 1,310,890 shares at $2.59 per share for $3.4 million gross, plus warrants. On July 30, 2026, holders exercised 1,202,965 Series C Warrants at $2.722 per share for $3.3 million gross.

  • Going Concern Warning Reiterated

    Management states substantial doubt about the company's ability to continue as a going concern, citing accumulated deficit of $325.7 million and negative cash flows. Existing capital is expected to fund operations into Q2 2027.

  • Nasdaq Listing Risk

    As of June 30, 2026, stockholders' equity was a deficit of $2.055 million, below the $2.5 million Nasdaq minimum. Pro forma equity after warrant reclassifications is $4.392 million, but delisting risk remains if compliance is not maintained.


Analysis · NUWE · Industrial Applications And Services

Nuwellis remains in a precarious financial position with a going concern warning, but the 10-Q reveals significant post-quarter financing that strengthens its cash position and pro forma equity. The company raised $6.7 million in gross proceeds through a registered direct offering and warrant exercises in late July, which management says extends its runway into Q2 2027. However, the stock trades near its 52-week low at $1.30, and the company faces Nasdaq delisting risk if it cannot maintain the $2.5 million minimum stockholders' equity requirement. The appointment of Mike McCormick as CEO effective June 30, 2026, adds a new leadership element.

At the time of this filing, NUWE was trading at $1.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $1.25 to $235.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUWE - Latest Insights

NUWE
Aug 13, 2026, 4:38 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.34
Real-time Price: $1.32 info
Change: -$0.0199 (-1%) info
Market Cap: $4.128M info
NUWE
Aug 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $1.32 info
Change: -$0.0824 (-6%) info
Market Cap: $4.128M info
NUWE
Aug 03, 2026, 4:35 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.58
Real-time Price: $1.32 info
Change: -$0.260 (-16%) info
Market Cap: $4.128M info
NUWE
Aug 03, 2026, 7:27 AM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.65
Real-time Price: $1.32 info
Change: -$0.330 (-20%) info
Market Cap: $4.128M info
NUWE
Jul 31, 2026, 8:42 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $1.32 info
Change: -$0.650 (-33%) info
Market Cap: $4.128M info